Physician profile
Gary Ruesch
NPI 1851381628
$504.11
in general payments reported to CMS, 2019-2025
9 companies · $96.14 in 2025
The $96.14 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.31 · 2022: $16.39 · 2023: $130 · 2024: $248 · 2025: $96.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $197.36 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $102.88 | 2022-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $61.51 | 2023-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $50.24 | 2023-2025 | Gardasil 9, Rotateq, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $34.57 | 2025 | Jornay Pm |
| Ipsen Biopharmaceuticals, INC | $23.53 | 2024 | Sohonos |
| Tris Pharma INC | $19.71 | 2024 | Dyanavel Xr |
| Astrazeneca Pharmaceuticals LP | $11.46 | 2021 | |
| Genentech USA, INC. | $2.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Ruesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.